Skip to content

SEARCH

Investing News
Biotech
Oil & Gas
Health
Mining
Cannabis
Energy
Tech
Health
MORE

Search

SEARCH FOR AN ARTICLE

Search

Investing News
Biotech
Oil & Gas
Health
Mining
Cannabis
Energy
Tech
Health
MORE

HomeNUMI-PR-30

NUMI-PR-30

Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD

Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD

July 12, 2021

LATEST NEWS

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from Micro Cap Watch.

I want e-mail alerts, updates, and offers and agree to the MicroCapWatch privacy policy.

Market Jar Media Inc. © 2024